CTX-I (CrossLaps®)

Product Description

The IDS-iSYS CTX-I (CrossLaps^®) Assay is intended for the quantitative determination of degradation products of C-terminal telopeptides of Type I collagen (CTX-I) in human serum or plasma on the IDS-iSYS Multi-Discipline Automated System.

Results are to be used in conjunction with other clinical and laboratory data to assist the clinician. CTX-I can be used as an indicator of bone resorption status as well as an aid in monitoring bone resorption changes during hormone replacement and bisphosphonate therapies.

• Exceptional sensitivity and reproducible results – meeting clinicians’ needs for monitoring therapy effectiveness, identifying non-adherent and non-responders to therapy
• Excellent correlation to established CTX-I assays – allowing seamless transition between methods
• Combining bone turnover markers with the established IDS-iSYS 25-Hydroxy Vitamin D^S and IDS-iSYS Intact PTH tests from a single sample tube – aiding management of osteoporosis and other metabolic bone diseases
• A reference marker for osteoporosis management as indicated by IOF, IFCC and NBHA
• Reduced tube handling – wide variety of sample types supported
• A complete clinical assay panel supporting bone disease management